JP1302
JP1302 is a potent, selective, high affinity antagonist of the α2C-adrenoceptor, with a Kb of 16 nM and a Ki of 28 nM for the human α2C-receptor. JP1302 shows antidepressant and antipsychotic-like effects. JP1302 can be used for neuropsychiatric disorders and renal dysfunction research[1][2][3].
Product Specifications
UNSPSC
12352005
Hazard Statement
H315, H319
Target
Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/jp1302.html
Purity
98.68
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
CN1CCN(C2=CC=C(NC3=C(C=CC=C4)C4=NC5=CC=CC=C53)C=C2)CC1
Molecular Formula
C24H24N4
Molecular Weight
368.47
Precautions
H315, H319
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-103213A/JP1302-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-103213A/JP1302-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
α adrenergic receptor
CAS Number
[80259-18-3]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Mouse Eukaryotic translation initiation factor 4B (EIF4B) ELISA Kit
Mouse Monoclonal Calicivirus Antibody (FCV1-43) [DyLight 594]
